Machine Learning

WelcomeVille Investment Association is launching a platform to fix 'cognitive drift'. Is this the future of professional development or a niche experiment?

WeVisu's AI platform is bringing stability to the chaotic home remodeling market, reducing costs and empowering contractors with unprecedented digital tools.

A $2.4B deal for AI's future. A hedge fund's strategic play. We decode the battle for Alphawave, the company powering the next tech revolution.

A hedge fund's 2.34% derivatives stake in Alphawave IP suggests a major acquisition by Qualcomm, highlighting a high-stakes battle for key chip IP.

A V2G pioneer pivots its intelligent software to compete for a massive national energy storage contract in South Korea's booming, high-stakes market.

ThoughtSpot's new suite of BI agents signals a major shift from static reports to autonomous action. But can it overcome the hurdles of trust and adoption?

Advanced AI is reshaping how destinations target travelers. These data-driven strategies offer a powerful playbook for healthcare's patient engagement challenges.

A new partnership seeks to unify viewership, channel, and ad data across all 210 US markets, promising unprecedented precision for local advertisers.

A struggling interactive entertainment firm bets its future on gold, targeting Malaysia's booming market. A look at the high-stakes pivot shaking up BHAT.

AI agents connect to your most critical systems, creating hidden risks. A new class of security tools aims to map and neutralize these invisible threats.

With a new patent, this biotech targets the massive orthopedics market. But can its novel fibroblast therapy overcome steep financial and clinical hurdles?

How a super-regional insurer's full-scale cloud modernization with Guidewire is a strategic move to boost agility and precision in challenging markets.

ADP's new retirement plan isn't just about lower fees. It's a tech-driven strategy to solve the SMB benefits gap and empower financial advisors.

A crypto fund's nomination for a top award signals a new era for family offices seeking managed risk and high returns in the volatile digital asset market.

With a key FAA filing, Electra's hybrid-electric EL9 moves closer to reality, promising to bypass airports with 150-foot takeoffs and landings.

Ontario's new FAST program speeds access to cancer drugs like Scemblix, challenging Canada's slow reimbursement system. Is this a new national blueprint?

Promising data for NuCana's NUC-7738 offers hope for tough-to-treat melanoma, but the biotech's financial health presents a critical hurdle.

With new clinical data and recent FDA approval, IceCure Medical's tumor-freezing tech is paving a new, less-invasive path for breast cancer treatment.

A new partnership signals a shift towards versatile, American-made drone systems, streamlining critical missions and challenging market incumbents.

The ESA's new elite summit, iicon, replaces E3, targeting C-suites to leverage gaming tech across healthcare, finance, and media. What's at stake?